Cipla eyes acquisitions after Covid windfall

Founded in 1935 by Hamied’s grandfather in then-colonial Bombay, Cipla made its name globally by pioneering the sale of cheap, generic HIV drugs across Africa at the turn of the millennium. Since then the Hamied family has sought to build Cipla into a major global pharmaceutical player, with a current focus on expanding in North America.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3oikyGS
via IFTTT